This announcement is a separate document:
上海市通力律师事务所关于江苏康为世纪生物科技股份有限公司2021年股票期权激励计划注销期权、调整行权价格及期权数量、第二个行权期行权条件成就等事项之法律意见书
Legal opinion of Shanghai Tongli Law Firm on matters such as cancellation of options in the 2021 stock option incentive plan of Jiangsu Kangwei Century Biotechnology Co., Ltd., adjustment of exercise prices and number of options, and fulfillment of the lic
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.